SEC Filing | SciPlay Corporation

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

OQuinn Daniel

(Last)

(First)

(Middle)

C/O SCIPLAY CORPORATION

6601 BERMUDA ROAD

(Street)

LAS VEGAS

89119

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/18/2023

3. Issuer Name and Ticker or Trading Symbol
SciPlay Corp [ SCPL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Interim CFO and Secretary

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock	7,770	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Units	⁽¹⁾	⁽¹⁾	Class A Common Stock	563	⁽¹⁾	D
Restricted Stock Units	⁽²⁾	⁽²⁾	Class A Common Stock	563	⁽²⁾	D
Restricted Stock Units	⁽³⁾	⁽³⁾	Class A Common Stock	2,000	⁽³⁾	D
Restricted Stock Units	⁽⁴⁾	⁽⁴⁾	Class A Common Stock	167	⁽⁴⁾	D
Restricted Stock Units	⁽⁵⁾	⁽⁵⁾	Class A Common Stock	6,670	⁽⁵⁾	D
Restricted Stock Units	⁽⁶⁾	⁽⁶⁾	Class A Common Stock	1,515	⁽⁶⁾	D
Restricted Stock Units	⁽⁷⁾	⁽⁷⁾	Class A Common Stock	2,272	⁽⁷⁾	D
Restricted Stock Units	⁽⁸⁾	⁽⁸⁾	Class A Common Stock	11,353	⁽⁸⁾	D

Explanation of Responses:

1. The restricted stock units ("RSUs") are scheduled to vest on September 20, 2023. Each RSU converts into a share of class A common stock on a one-for-one basis.

2. The RSUs are scheduled to vest on September 20, 2023. These RSUs were granted subject to achievement of a performance condition, which condition has been achieved. Each RSU converts into a share of class A common stock on a one-for-one basis.

3. The RSUs are scheduled to vest in equal installments on September 21, 2023 and September 21, 2024. Each RSU converts into a share of class A common stock on a one-for-one basis.

4. The RSUs are scheduled to vest on March 20, 2023. Each RSU converts into a share of class A common stock on a one-for-one basis.

5. The RSUs are scheduled to vest on March 16, 2023 and March 16, 2024 as to 3,330 and 3,340 shares, respectively. Each RSU converts into a share of class A common stock on a one-for-one basis.

6. The RSUs are scheduled to vest on September 20, 2023 and September 20, 2024 as to 757 and 758 shares, respectively. Each RSU converts into a share of class A common stock on a one-for-one basis.

7. The RSUs are scheduled to vest on March 1, 2023 as to 757 shares, with the balance scheduled to vest on September 20, 2023 and September 20, 2024 as to 757 and 758 shares, respectively. These RSUs were granted subject to achievement of a performance condition, which condition has been achieved. Each RSU converts into a share of class A common stock on a one-for-one basis.

8. The RSUs are scheduled to vest on September 20, 2023 as to 3,784 shares, with the balance scheduled to vest on September 20, 2024 and September 20, 2025 as to 3,784 and 3,785 shares, respectively. Each RSU converts into a share of class A common stock on a one-for-one basis.

	/s/ Sweta Gabhawala, attorney-in-fact for Daniel O'Quinn	02/28/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Exhibit 24

POWER OF ATTORNEY

KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints each of James Sottile, Robert Gustafson and Sweta Gabhawala, signing singly, the undersigned’s true and lawful attorneys-in-fact to:

execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of SciPlay Corporation (the “Company”), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 and 5, and any amendments thereto, and timely file such form or report with the Securities and Exchange Commission and any stock exchange or similar authority; and

take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney supersedes any Power of Attorney previously granted by the undersigned with respect to the foregoing matters and shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on this 28^th day of February, 2023.


		/s/ Daniel O’Quinn
		Daniel O’Quinn